Structure

The Biobank is a collaborative organization with long term partnerships established between PROCURE, the four Québec universities, with the Fonds de recherche en santé du Québec and other key groups to be confirmed over time. The Biobank will have its own Scientific and Lay Advisory Board and staff including both management and operations resources. The world class Scientific and Lay Advisory Board will oversee the accomplishment of the long-term scientific goals of the Biobank and will establish new goals and initiatives over time. As the Biobank will act as a guardian of biological materials and data, strict policies, procedures and appropriate controls will be developed and put in place according to worldwide best practices. Adherence to these practices will insure that high quality scientific data is generated downstream.

The overarching basis for tissue and material distribution will be a merit based review system, whereby research proposals submitted will be regularly reviewed for selection by the Biomaterials Use Committee comprised of representatives from the universities, PROCURE and other stakeholder communities.

The Biobank is governed by the Biobank Central Committee, made up of representatives from each of the four university health centres, PROCURE Board members, Biobank management and chaired by Dr. Armen Aprikian of the MUHC. The Biobank Central Committee reports directly to the PROCURE Board of Directors. The current committee members are the following:

• Armen Aprikian, M.D., Chairman, Principal Investigator for McGill University
• Cédric Bisson, M.D., L.L. B., PROCURE Board member
• Michel Carmel, M.D., Principal Investigator for Université de Sherbrooke
• Mark Bordeleau , PROCURE Executive Director
• Louis Lacombe, M.D., Principal Investigator for Université Laval
• Anne-Marie Mes-Masson, Ph.D., FRSQ
• Fred Saad, M.D., Principal Investigator for Université de Montréal